Key result
Methamphetamine use in heart failure patients was associated with decreased left ventricular ejection fraction and increased left ventricular mass index compared to non-users.
Why the study?
Does methamphetamine use in heart failure patients associate with worse echocardiographic findings compared to non-users?
Case-Control (n=522)
No
Does methamphetamine use in heart failure patients associate with worse echocardiographic findings compared to non-users?
Methamphetamine use in heart failure patients is associated with echocardiographic findings indicative of worse dilated cardiomyopathy compared to non-users.
Answers are grounded in this paper and cite their sources.
Methamphetamine screening may be warranted in HF; leaves open whether abstinence improves LVEF in prospective studies.
± 25.44; p=0.0000) and marginally significant right ventricle systolic pressure (42.29mmHg ± 17.53 vs. 39.59mmHg ± 15.61; p=0.0540) Conclusion Our results indicated that methamphetamine users had echocardiogram findings with decreased ejection fraction and increased left ventricular mass index, end-diastolic volume index, and right ventricular systolic pressure consistent with worse dilated cardiomyopathy comparison to non-users.
No takes yet. Share an insight, caveat, or question.
Jariwal et al. (2021) conducted a case-control in Heart Failure (n=522). Methamphetamine use vs. Non-methamphetamine users was evaluated on Left ventricle ejection fraction (p=0.0000). Methamphetamine use in heart failure patients was associated with decreased left ventricular ejection fraction and increased left ventricular mass index compared to non-users.
Synapse has enriched 10 related papers. Consider them for comparative context: